Olema Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, has announced the issuance of stock options to four new employees, allowing them to purchase a total of 124,000 shares of the company's common stock. These stock options, effective September 2, 2025, are part of Olema's 2022 Inducement Plan. The options vest over a four-year period, with 25 percent vesting after the first year and the remainder vesting monthly over the next three years. The exercise price is set at $6.47 per share, reflecting the last reported sale price on Nasdaq as of the effective date. The options have a 10-year term.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Olema Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9522687-en) on September 03, 2025, and is solely responsible for the information contained therein.